Davisson Muriel T, Bergstrom David E, Reinholdt Laura G, Donahue Leah Rae
The Jackson Laboratory, Bar Harbor, Maine, U.S.A.
Curr Protoc Mouse Biol. 2012 Jun 1;2:103-118. doi: 10.1002/9780470942390.mo110200.
Historically, spontaneous mutations in mice have served as valuable models of heritable human diseases, contributing substantially to our understanding of both disease mechanisms and basic biological pathways. While advances in molecular technologies have improved our ability to create mouse models of human disease through targeted mutagenesis and transgenesis, spontaneous mutations continue to provide valuable research tools for discovery of novel genes and functions. In addition, the genetic defects caused by spontaneous mutations are molecularly similar to mutations in the human genome and, therefore often produce phenotypes that more closely resemble those characteristic of human disease than do genetically engineered mutations. Due to the rarity with which spontaneous mutations arise and the animal intensive nature of their genetic analysis, large-scale spontaneous mutation analysis has traditionally been limited to large mammalian genetics institutes. More recently, ENU mutagenesis and new screening methods have increased the rate of mutant strain discovery, and high-throughput DNA sequencing has enabled rapid identification of the underlying genes and their causative mutations. Here, we discuss the continued value of spontaneous mutations for biomedical research.
从历史上看,小鼠的自发突变一直是人类遗传性疾病的宝贵模型,极大地促进了我们对疾病机制和基本生物学途径的理解。虽然分子技术的进步提高了我们通过靶向诱变和转基因技术创建人类疾病小鼠模型的能力,但自发突变仍然为发现新基因和功能提供了有价值的研究工具。此外,自发突变引起的遗传缺陷在分子层面上与人类基因组中的突变相似,因此,与基因工程突变相比,它们通常产生的表型更接近人类疾病的特征。由于自发突变出现的频率很低,且其遗传分析需要大量动物,传统上大规模自发突变分析仅限于大型哺乳动物遗传学研究所。最近,ENU诱变和新的筛选方法提高了突变株的发现率,高通量DNA测序能够快速鉴定潜在基因及其致病突变。在此,我们讨论自发突变在生物医学研究中的持续价值。